Edition:
United Kingdom

CRISPR Therapeutics AG (CRSP.OQ)

CRSP.OQ on NASDAQ Stock Exchange Global Market

49.04USD
19 Jul 2019
Change (% chg)

$-0.68 (-1.37%)
Prev Close
$49.72
Open
$49.98
Day's High
$50.00
Day's Low
$48.61
Volume
133,818
Avg. Vol
142,620
52-wk High
$60.00
52-wk Low
$22.23

About

CRISPR Therapeutics AG is a Switzerland-based gene-editing company. It focuses on the development of transformative gene-based medicines for serious diseases. The Company develops its products using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform, which allows for precise directed... (more)

Overall

Beta: --
Market Cap(Mil.): $2,594.71
Shares Outstanding(Mil.): 52.91
Dividend: --
Yield (%): --

Financials

  CRSP.OQ Industry Sector
P/E (TTM): -- 97.98 34.52
EPS (TTM): -3.74 -- --
ROI: -44.62 7.77 12.69
ROE: -55.24 8.27 17.17

BRIEF-Crispr Therapeutics Reports Q1 Results, Provides Business Update

* CRISPR THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS

29 Apr 2019

BRIEF-Crispr Therapeutics And Vertex Announce FDA Fast Track Designation For CTX001 For Treatment Of Beta Thalassemia

* CRISPR THERAPEUTICS AND VERTEX ANNOUNCE FDA FAST TRACK DESIGNATION FOR CTX001 FOR THE TREATMENT OF BETA THALASSEMIA Source text for Eikon: Further company coverage:

16 Apr 2019

Earnings vs. Estimates